Jiangsu Hualan Stock Hits Day High with Strong 3.35% Intraday Surge

Jiangsu Hualan New Pharmaceutical Material Co., Ltd. has experienced a notable increase of 3.35% on June 15, 2026, reaching an intraday high of CNY 125.50. This performance stands out against the backdrop of the China Shanghai Composite, which rose by 1.61% on the same day. Over the past month, Jiangsu Hualan has shown a significant gain of 21.8%, contrasting sharply with the Composite's decline of 0.94%. The company's year-to-date performance is particularly impressive, boasting a 144.32% increase compared to the Composite's modest 3.22%. Despite these short-term gains, the company faces challenges in management efficiency, reflected in a low Return on Capital Employed (ROCE) of 9.64%. Additionally, the company has reported a decline in net sales and operating profit over the past five years, with negative results for the last seven consecutive quarters. With a market capitalization of CNY 19,342 million, Jiangsu Hualan operates within the packaging industry, but its financial metrics indicate areas of concern that may impact its long-term growth trajectory.